University of California San Francisco
Give to UCSF
This story is one in a series of first-person perspectives from those who are working on the frontlines to better understand, treat and prevent transmission of HIV and AIDS as well as COVID-19. You
Researchers from the UCSF School of Nursing have joined a newly launched national collaborative to study the impacts of COVID-19 on members of the lesbian, gay, bisexual, transgender and queer communities.
UCSF researchers have found a way to double doctors’ accuracy in detecting the vast majority of complex fetal heart defects in utero.
The partnership will allow the company and the University to develop technology that will enable a modern, more streamlined experience for patients and set a new standard for health care delivery.
Six health care experts grapple with how to address race without being racist.
Kim Rhoads, MD, MPH, founded Umoja Health Partners to unite about 30 community organizations combating COVID-19 in the Bay Area’s Black communities. She shares why the Umoja approach is working.
For patients who can utilize the technology, particularly for follow-up care after a diagnosis has already been made, the benefits of telehealth are overwhelming.
Pioneering neural recordings in patients with Parkinson’s disease by UCSF scientists are providing the groundwork for personalized brain stimulation to treat Parkinson’s and other neurological disorders.
Games and supplements claim to strengthen memory and cognition. Should you buy them?
UCSF has been granted renewed accreditation from the WASC Senior College and University Commission (WSCUC) for the maximum ten-year accreditation period. WSCUC accreditation ensures that an institution meets rigorous standards of quality and integrity and allows students enrolled in the institution to receive Title IV federal financial aid funding.
In the third installment of UCSF’s three-part series, “COVID-19: The Path Forward,” a panel of health and policy experts met March 23 to examine COVID-19's impact on our society and look ahead to how we rebuild and prepare for future pandemics.
Scientists at UC San Francisco, UC Berkeley and UCLA have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient’s own blood-forming stem cells.
UC San Francisco’s Schools of Medicine and Nursing received top ratings in this year’s U.S. News & World Report rankings of best graduate and professional schools.
